{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T20:09:48Z","timestamp":1788206988276,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jchf.2020.09.014","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T21:55:48Z","timestamp":1607550948000},"page":"137-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Reverse Cardiac Remodeling Following Initiation of Sacubitril\/Valsartan in Patients With Heart Failure With and Without Diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Muhammad Shahzeb","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Michael","family":"Felker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana L.","family":"Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devavrat","family":"Bapat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrien E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.","family":"Maisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret F.","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2020.09.014_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004646","article-title":"Trends in noncardiovascular comorbidities among patients hospitalized for heart failure","volume":"11","author":"Sharma","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib2","first-page":"136","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2020.09.014_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.amjmed.2006.05.024","article-title":"Diabetes in heart failure: prevalence and impact on outcome in the population","volume":"119","author":"From","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jchf.2020.09.014_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2014.09.002","article-title":"Concomitant diabetes mellitus and heart failure","volume":"40","author":"Dei Cas","year":"2015","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ahj.2011.07.015","article-title":"Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both","volume":"162","author":"Shah","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2020.09.014_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the reduction of atherothrombosis for continued health (REACH) registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2020.09.014_bib8","volume":"8","author":"Yap","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2020.09.014_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1479164116653342","article-title":"Diabetes mellitus is associated with adverse structural and functional cardiac remodelling in chronic heart failure with reduced ejection fraction","volume":"13","author":"Walker","year":"2016","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jchf.2020.09.014_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12872-015-0018-0","article-title":"Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis","volume":"15","author":"Sun","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2020.09.014_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2337\/dc12-1116","article-title":"Influence of diabetes on left ventricular systolic and diastolic function and on long-termoutcome after cardiac resynchronization therapy","volume":"36","author":"H\u00f6ke","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2020.09.014_bib12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2020.09.014_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights from prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2019.12821","article-title":"Association of change in N-terminal pro\u2013B-type natriuretic peptide following initiation of sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2020.09.014_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ahj.2017.12.021","article-title":"Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril\/Valsartan Therapy for Heart\u00a0Failure (PROVE-HF)","volume":"199","author":"Januzzi","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2020.09.014_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2020.09.014_bib18","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jacc.2016.06.061","article-title":"Prognostic implications of type 2 diabetes mellitus in ischemic and nonischemic heart failure","volume":"68","author":"Johansson","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib19","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","article-title":"Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2020.09.014_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ejhf.679","article-title":"In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart\u00a0Failure Long-Term Registry","volume":"19","author":"Targher","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1755-5922.12183","article-title":"Pharmacodynamic and pharmacokinetic profiles of sacubitril\/valsartan (LCZ696) in patients with heart failure and reduced ejection fraction","volume":"34","author":"Kobalava","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.jchf.2020.09.014_bib22","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/jc.2004-1953","article-title":"Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans","volume":"90","author":"Birkenfeld","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jchf.2020.09.014_bib23","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.2337\/db08-0649","article-title":"Atrial natriuretic peptide induces postprandial lipid oxidation in humans","volume":"57","author":"Birkenfeld","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jchf.2020.09.014_bib24","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1172\/JCI64526","article-title":"Natriuretic peptides enhance the oxidative capacity of human skeletal muscle","volume":"122","author":"Engeli","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jchf.2020.09.014_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S2213-8587(17)30089-X","article-title":"Glycaemic control in heart failure: a PARADIGM shift for patients with concomitant diabetes?","volume":"5","author":"Giamouzis","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2020.09.014_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tips.2014.05.003","article-title":"Turning on cGMP- dependent pathways to treat cardiac dysfunctions: boom, bust, and beyond","volume":"35","author":"Lukowski","year":"2014","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jchf.2020.09.014_bib27","article-title":"The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction","volume":"2","author":"Greene","year":"2013","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jchf.2020.09.014_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ejhf.711","article-title":"Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes","volume":"19","author":"Matyas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib29","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1161\/CIRCHEARTFAILURE.111.961706","article-title":"Differential expression of PDE5 in failing and nonfailing human myocardium","volume":"5","author":"Shan","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2008-1073128","article-title":"Increased aldosterone levels in a model of type 2 diabetes mellitus","volume":"117","author":"Fredersdorf","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.jchf.2020.09.014_bib31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/CIRCHEARTFAILURE.110.959882","article-title":"Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction: a study across therapeutic eras","volume":"4","author":"Cubbon","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2020.09.014_bib32","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1479164115573225","article-title":"Sudden cardiac death in patients with diabetes mellitus and chronic heart failure","volume":"12","author":"Walker","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.jchf.2020.09.014_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.hrthm.2017.11.012","article-title":"Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable defibrillator devices","volume":"15","author":"de Diego","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jchf.2020.09.014_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1007\/s00392-019-01440-y","article-title":"Sacubitril\/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction","volume":"108","author":"Martens","year":"2019","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib35","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2020.09.014_bib36","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177920305783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:56:38Z","timestamp":1761972998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177920305783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213177920305783"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.014","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reverse Cardiac Remodeling Following Initiation of Sacubitril\/Valsartan in Patients With Heart Failure With and Without Diabetes","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2020.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}